Author
The University of Texas MD Anderson Cancer CenterORCID 0000-0002-4741-7925Unclaimed ORCID profile · follow to get notified of new preprints
3 papers
Recent·Most cited
Aleksey Lazarenkov, Gemma Valcárcel, Alba Martínez…·José Luis Sardina
The paper identifies a TET2-AGO2 regulatory axis that links epigenetic remodeling to myeloid commitment and leukemia progression.
Juan José Rodríguez‐Sevilla, Irene Gañán‐Gómez, Feiyang Ma…·Simona Colla
This study shows MDS hematopoietic stem cells reprogram their differentiation state to bypass venetoclax sensitivity through genetic mutations and transcriptional changes.
Vera Ademà, Irene Gañán‐Gómez, Feiyang Ma…·Simona Colla
This study shows that IL-1B-mediated inflammation drives ineffective erythropoiesis in early-stage MDS and that canakinumab can reduce transfusion dependence in patients with DNMT3A and TET2 mutations.